Helmerich & Payne (HP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Nov, 2025Executive summary
Q3 FY25 saw strong operating performance, with adjusted EBITDA of $268 million and adjusted earnings of $22 million, despite a consolidated net loss of $163 million due to $173 million in non-cash goodwill impairment, primarily from the KCAD acquisition.
Operating revenues rose to $1.04 billion, up 49% year-over-year, driven by the $2.0 billion KCA Deutag acquisition, which expanded international and offshore operations.
Integration of KCAD is nearly 75% complete, with $50 million in cost synergies identified toward a $50–$75 million target.
Debt repayment progress includes $120 million repaid through July, with $200 million targeted by year-end 2025.
All eight unconventional FlexRigs in Saudi Arabia have commenced operations, supporting international expansion.
Financial highlights
Q3 FY25 operating revenues were $1.04 billion, with direct margin of $266 million (North America), $34 million (International), and $23 million (Offshore).
Adjusted EBITDA was $268 million; adjusted EPS was $0.22, while diluted EPS was $(1.64) due to goodwill impairment.
Cash and short-term investments totaled $187 million, with an undrawn $950 million credit facility.
Net loss attributable to shareholders was $162.8 million, compared to net income of $88.7 million in Q3 FY24.
Operating cash flow for the nine months ended June 30, 2025, was $336 million.
Outlook and guidance
Q4 direct margin guidance: $230–$250 million (North America), $22–$32 million (International), $22–$30 million (Offshore), with 138–144 rigs in North America and 62–66 internationally.
Full-year 2025 capital expenditures forecast at $380–$395 million; depreciation at $595 million; cash taxes at $190–$220 million; interest expense for Q4 at $25 million.
Backlog increased to $7.3 billion as of June 30, 2025, with 27.8% expected to be fulfilled by fiscal 2026.
Management expects cost savings from acquisition synergies and restructuring to become evident in future quarters.
2026 CapEx expected to decrease, with spend front-loaded in 2025.
Latest events from Helmerich & Payne
- All board proposals passed with strong support, marking a smooth CEO transition.HP
AGM 20264 Mar 2026 - $230M EBITDA, $1B+ revenue, $97M net loss, $260M debt repaid, strong global growth.HP
Q1 20265 Feb 2026 - $1.97B KCA Deutag deal creates a global leader, boosts cash flow, and expands international scale.HP
Q3 20243 Feb 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.HP
Proxy Filing22 Jan 2026 - Shareholders to vote on board, auditor, executive pay, and expanded incentive plan amid strong results.HP
Proxy Filing22 Jan 2026 - Strong FY24, global expansion via KCA Deutag, and lower 2025 CapEx to drive cash flow.HP
Q4 202414 Jan 2026 - KCA Deutag acquisition expands global scale as Q1 profit drops on higher costs.HP
Q1 202517 Dec 2025 - 2024 saw robust results, global growth, and strong governance, with all board proposals recommended.HP
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect directors, approve pay, and ratify auditors in March 2025.HP
Proxy Filing1 Dec 2025